Effect of agents increasing the resistance of the vascular wall as well as of trasylol (a protease inhibitor) on experimental brain edema
Czernicki, Z.
Neurologia i Neurochirurgia Polska 11(4): 457-460
1977
ISSN/ISBN: 0028-3843 PMID: 302426 Document Number: 120751
Document emailed within 1 workday
Related Documents
Takagi, H.; Marmarou, A. 1983: Experimental studies of brain edema by infusion edema model-- biophysical changes of edema fluid in white matter of the brain No Shinkei Geka. Neurological Surgery 11(11): 1141-1146Synovets, A.S.; Pustovoĭt, P.I.; Levitskiĭ, A.P. 1983: Effect of the protease inhibitor contrical on liver and serum proteolytic enzyme activity in experimental cholestasis Klinicheskaia Khirurgiia 9: 66-67
Sviridov, L.P.; Stepanov, A.V. 1990: Prolongation of the effect of immunostimulators as means of increasing resistance to causative agents of infection Antibiotiki i Khimioterapiia 35(5): 32-35
Trinus, F.P.; Mokhort, N.A. 1972: Effect of non-steroid anti-inflammatory agents on vascular wall and cell membrane permeabilities Farmakologiia i Toksikologiia 35(1): 60-63
Avikainen, V.; Eklund, B. 1974: Disseminated intravascular coagulation after inhibition of fibrinolysis with tranexamic acid (AMCA) and proteinase inhibitor Trasylol in experimental traumatic and haemorrhagic shock Annales Chirurgiae et Gynaecologiae Fenniae 63(3): 226-234
Race, E. 2001: Cross-resistance within the protease inhibitor class Antiviral Therapy 6(Suppl 2): 29-36
Ala, P.J.; Rodgers, J.D.; Chang, C.H. 1999: HIV protease drug resistance and its impact on inhibitor design Current Opinion in Drug Discovery and Development 2(4): 265-273
Zabrodin, O.N.; Lebedev, S.N. 1979: Effect of neurotropic agents on the healing of experimental mucosal erosions and on the noradrenaline content in the stomach wall Farmakologiia i Toksikologiia 42(5): 484-487
Taiwo, B.O.; Hicks, C.B. 2007: Darunavir: an overview of an HIV protease inhibitor developed to overcome drug resistance Aids Reader 17(3): 151-156; 159-161
Oĭvin, I.A.; Gaponiuk, P.I.; Oĭvin, V.I.; Tokarev, O.I.; Volodin, V.M. 1972: Mechanisms involved in increasing the vascular permeability under the effect of permeability factors (histamine, serotonin, Bradykinin and inflammatory agents Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 16(4): 19-23
Livshits, B.M. 1993: The effect of hyperbaric oxygenation on the manifestation of brain edema at different periods of an acute experimental compression-dislocation syndrome Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 93(1): 61-63
Shalit, M.N. 1974: Effect of intracarotid artery administration of mannitol on cerebral blood flow and intracranial pressure in experimental brain edema Israel Journal of Medical Sciences 10(6): 577-580
Luber, A.D. 2005: Use of acid-reducing agents in protease inhibitor-based HAART and the potential for negative treatment outcomes Aids Reader 15(12): 692
Gaillard, M.C.; Reichberg, S.B.; Nogueira, C.M.; Kilroe-Smith, T.A. 1993: Differences in elastase-binding activity of alpha 1-protease inhibitor and alpha 2-macroglobulin for asthma patients and control subjects with various alpha 1-protease inhibitor phenotypes Clinical Chemistry 39(4): 675-679
Tomaszewski, J.; Hanzlik, J.; Wolański, I.; Grzywa, M.; Donica, H.; Woźniak, K.; Iłenda, M. 1979: Studies on the chemical composition of the vascular wall. XVIII. Glycosoaminoglycans of the aortic wall in rabbits on an atherogenic diet and after the production of experimental hyperthyroidism Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 34: 277-282
Marcelin, A.-G.; Flandre, P.; de Mendoza, C.; Roquebert, B.; Peytavin, G.; Valer, L.; Wirden, M.; Abbas, S.; Katlama, C.; Soriano, V.; Calvez, V. 2007: Clinical validation of saquinavir/ritonavir genotypic resistance score in protease-inhibitor-experienced patients Antiviral Therapy 12(2): 247-252
Wiznitzer, T.; Loewenthal, M.; Michowitz, M.; Wishnievsky, M. 1973: The effect of Trasylol on experimental endotoxic shock and hemorrhagic necrosis of the intestine Harefuah 84(7): 368-372
Joo, K.M.; Song, S.Y.; Park, K.; Kim, M.H.; Jin, J.; Kang, B.G.; Jang, M.J.; Lee, G.S.; Kim, M.S.; Nam, D.-H. 2008: Response of brain specific microenvironment to P-glycoprotein inhibitor: an important factor determining therapeutic effect of P-glycoprotein inhibitor on brain metastatic tumors International Journal of Oncology 33(4): 705-712
Borzeix, M.G.; Labos, M.; Cahn, J. 1972: Experimental model of brain edema for the study of drugs acting on blood flow and-or brain metabolism Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 13(4): 257-260
Wakayama, T.; Itoh, T.; Shibayama, K.; Idezuki, Y. 1989: Prevention of the spread of experimental acute pancreatitis by intraductal administration of a synthetic protease inhibitor in dogs American Journal of Gastroenterology 84(3): 272-278